Top

Published in:

01-08-2022 | Alogliptin | Clinical study

Some DPP-4 inhibitors may increase risk of angioedema

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Some dipeptidyl peptidase-4 (DPP-4) inhibitors appear to be associated with an increased risk of angioedema, with and without concomitant use of ACE inhibitors, according to findings of a study published in Nature. …

Ohyama K, et al. Pharmacovigilance study of the association between dipeptidyl peptidase?4 inhibitors and angioedema using the FDA Adverse Event Reporting System (FAERS) Scientific Reports : 5 Aug 2022. Available from: URL: https://doi.org/10.1038/s41598-022-17366-x

Title: Some DPP-4 inhibitors may increase risk of angioedema
Publication date: 01-08-2022
Publisher: Springer International Publishing
Keywords: Alogliptin
Sitagliptin
Angioedema
Vildagliptin
Saxagliptin
Linagliptin
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-20954-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Some DPP-4 inhibitors may increase risk of angioedema

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Apixaban/aspirin/dexamethasone

Edoxaban/rivaroxaban

Adagrasib

Atomoxetine/imipramine

Methotrexate

Heparin